These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714 [TBL] [Abstract][Full Text] [Related]
46. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464 [TBL] [Abstract][Full Text] [Related]
47. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors? Garcia N; Bozzini N; Baiocchi G; da Cunha IW; Maciel GA; Soares Junior JM; Soares FA; Baracat EC; Carvalho KC Hum Pathol; 2016 Apr; 50():43-50. PubMed ID: 26997437 [TBL] [Abstract][Full Text] [Related]
48. Cell proliferation and expression of EGF, TGF-alpha, and EGF receptor in the developing primary palate. Iamaroon A; Tait B; Diewert VM J Dent Res; 1996 Aug; 75(8):1534-9. PubMed ID: 8906120 [TBL] [Abstract][Full Text] [Related]
49. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma. Matsuo H; Kurachi O; Shimomura Y; Samoto T; Maruo T Oncology; 1999 Oct; 57 Suppl 2():49-58. PubMed ID: 10545803 [TBL] [Abstract][Full Text] [Related]
50. Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa. Mozzachio K; Moore AB; Kissling GE; Dixon D Toxicol Pathol; 2016 Apr; 44(3):450-7. PubMed ID: 26692562 [TBL] [Abstract][Full Text] [Related]
51. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity. de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922 [TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-alpha, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas. Maruno M; Kovach JS; Kelly PJ; Yanagihara T J Neurosurg; 1991 Jul; 75(1):97-102. PubMed ID: 2045927 [TBL] [Abstract][Full Text] [Related]
53. Immunoexpression of p53 in cutaneous and subcutaneous leiomyosarcomas. Fernandez-Flores A; Monteagudo C Ann Diagn Pathol; 2016 Oct; 24():25-9. PubMed ID: 27649950 [TBL] [Abstract][Full Text] [Related]
54. Atypical uterine leiomyoma: a case report and review of the literature. Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982 [TBL] [Abstract][Full Text] [Related]
55. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Schwetye KE; Pfeifer JD; Duncavage EJ Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187 [TBL] [Abstract][Full Text] [Related]
56. The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms. Yavuz E; Güllüoğlu MG; Akbaş N; Tuzlali S; Ilhan R; Iplikçi A; Akhan SE Pathol Int; 2001 Dec; 51(12):938-41. PubMed ID: 11844066 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma. Liang Y; Zhang X; Chen X; Lü W Int J Clin Exp Pathol; 2015; 8(6):7196-202. PubMed ID: 26261614 [TBL] [Abstract][Full Text] [Related]
58. p53 protein overexpression in smooth muscle tumors of the uterus. Niemann TH; Raab SS; Lenel JC; Rodgers JR; Robinson RA Hum Pathol; 1995 Apr; 26(4):375-9. PubMed ID: 7705814 [TBL] [Abstract][Full Text] [Related]
59. Involvement of parathyroid hormone-related peptide in cell proliferation activity of human uterine leiomyomas. Yoshida M; Ohtsuru A; Samejima T; Okazaki M; Fujishita A; Ito M; Yamashita S; Ishimaru T Endocr J; 1999 Feb; 46(1):81-90. PubMed ID: 10426571 [TBL] [Abstract][Full Text] [Related]
60. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma]. Zhu XQ; Shi YF; Cheng XD; Wu YZ Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]